… co-founder and managing director of A2M Pharma, a spin-off from the former Schwarz Pharma. He has more than 15 years …

… commercial purposes. She served as Vice President of GOAT from 1992 until the sale of the company in April 2006. … as Kinshasa, Manila and Kuala Lumpur signaled a shift from superpower dominance toward a growing awareness of the … to South Africa to meet Nelson Mandela upon his release from prison. Championing the causes of the developing world …

… Neurotrophic factors like GDNF protect dopaminergic neurons from degenerating in animal models of PD, but have so far … GDNF or MANF to try to protect the dopaminergic neurons from degenerating. We will deliver MANF or GDNF to the … Sonofi-Aventis By John Commissiong The neuroprotection data from the MJFF project were used in this presentation. 2. To …

… significant variability in how the disease manifests itself from patient to patient,” said Sarah Orsay, chief executive … to propose research that would make use of existing data from well-characterized populations of Parkinson’s patients. … own institutions for various purposes. Others will work from some of the most important clinical research …

… (JNK) signaling pathway. Dr. Silva received his BA degree from Boston University and a PhD degree from The City University of New York. Emory University … cell death. Dr. Sherer received a B.S. degree in psychology from Duke University and a Ph.D. in neuroscience from The …

… raising money for various causes. This year, the proceeds from Los Producers Charity Show on November 13 — the eve … Going into the event, the show secured over $135,000 from sponsors alone. “Being in the entertainment industry, I … more about Los Producers Charity Show, check out coverage from the event in The Los Angeles Times ,   Billboard  and …